What changed in this filing

/stocks — the workspaceLOADING

Item 9A. Controls and Procedures

2021-02-18 compared with 2020-02-20 · 213 added, 492 removed, 113 unchanged (86% of the section changed)

1 unchanged sentence

Evaluation of Disclosure Controls and Procedures

Our Chief Executive Officer and Chief Financial Officer, with the participation of other members of management, have evaluated the

effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e)) under the Securities and Exchange Act of 1934, as amended, as of

the end of the period covered by this report.

Based on such evaluations, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective (at the reasonable assurance

level) to ensure that the information required to be included in this report has been recorded, processed, summarized and reported within the time periods specified in the SECs rules and forms and to ensure that the information required to be

included in this report was accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

Our Chief Executive Officer and Chief Financial Officer, with the participation of other members of management, have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e)) under the Securities and Exchange Act of 1934, as amended, as of the end of the period covered by this report.

Based on such evaluations, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective (at the reasonable assurance level) to ensure that the information required to be included in this report has been recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and to ensure that the information required to be included in this report was accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

There have been no changes in internal control over financial reporting that occurred during the period that have materially affected or are

reasonably likely to materially affect our internal controls over financial reporting.

Managements report on internal control over

financial reporting is included herein at page 171.

The attestation report from Deloitte & Touche LLP, our independent

registered public accounting firm, on our internal control over financial reporting is included herein at page 172.

There have been no changes in internal control over financial reporting that occurred during the period that have materially affected or are reasonably likely to materially affect our internal controls over financial reporting.

Management’s report on internal control over financial reporting is included herein at page 134.

The attestation report from Deloitte & Touche LLP, our independent registered public accounting firm, on our internal control over financial reporting is included herein at page 135.

Other Information

1 unchanged sentence

We are responsible for the preparation and integrity of the consolidated financial statements appearing in our Annual Report on Form 10-K.

The consolidated financial statements were prepared in conformity with accounting principles generally accepted in the United States of America and include amounts based on managements estimates and

The consolidated financial statements were prepared in conformity with accounting principles generally accepted in the United States of America and include amounts based on management’s estimates and judgments.

All other financial information in this report has been presented on a basis consistent with the information included in the consolidated financial statements.

We are also responsible for establishing and maintaining adequate internal controls over financial reporting (as defined in Rule 13a-15(f) under the Securities and Exchange Act of 1934, as amended).

We maintain a system of internal controls that is designed to provide reasonable assurance as to the fair and reliable preparation and

presentation of the consolidated financial statements, as well as to safeguard assets from unauthorized use or disposition.

environment is the foundation for our system of internal control over financial reporting and is embodied in our Code of Conduct.

We maintain a system of internal controls that is designed to provide reasonable assurance as to the fair and reliable preparation and presentation of the consolidated financial statements, as well as to safeguard assets from unauthorized use or disposition.

Our control environment is the foundation for our system of internal control over financial reporting and is embodied in our Code of Conduct.

It sets the tone of our organization and includes factors such as integrity and ethical values.

Our internal control

over financial reporting is supported by formal policies and procedures which are reviewed, modified and improved as changes occur in business conditions and operations.

The Audit and Compliance Committee of the Board of Directors, which is composed solely of outside directors, meets periodically with members

of management, the internal auditors and the independent registered public accounting firm to review and discuss internal control over financial reporting and accounting and financial reporting matters.

The independent registered public accounting

firm and internal auditors report to the Audit and Compliance Committee and have full and free access to the Audit and Compliance Committee at any time.

We conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control

Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

This evaluation included review of the documentation of controls, evaluation of the design effectiveness of controls, testing of

the operating effectiveness of controls and a conclusion on this evaluation.

Our internal control over financial reporting is supported by formal policies and procedures which are reviewed, modified and improved as changes occur in business conditions and operations.

The Audit and Compliance Committee of the Board of Directors, which is composed solely of outside directors, meets periodically with members of management, the internal auditors and the independent registered public accounting firm to review and discuss internal control over financial reporting and accounting and financial reporting matters.

The independent registered public accounting firm and internal auditors report to the Audit and Compliance Committee and have full and free access to the Audit and Compliance Committee at any time.

We conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

This evaluation included review of the documentation of controls, evaluation of the design effectiveness of controls, testing of the operating effectiveness of controls and a conclusion on this evaluation.

We have concluded that our internal control over financial reporting was effective as of December 31, 2020, based on these criteria.

Deloitte & Touche LLP, an independent registered public accounting firm, has issued an attestation report on our internal control

over financial reporting, which is included herein.

We do not expect that our disclosure controls and procedures or our internal controls

will prevent all errors and all fraud.

Deloitte & Touche LLP, an independent registered public accounting firm, has issued an attestation report on our internal control over financial reporting, which is included herein.

We do not expect that our disclosure controls and procedures or our internal controls will prevent all errors and all fraud.

A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met.

Further, the design of a control system must

reflect the fact there are resource constraints and the benefits of controls must be considered relative to their costs.

Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all

control issues and instances of fraud, if any, within the Company have been detected.

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Further, the design of a control system must reflect the fact there are resource constraints and the benefits of controls must be considered relative to their costs.

Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected.

REPORT OF I NDEPE N DENT REG I STERED PUBLIC ACCOUNTING FIRM

To the Stockholders and the Board of Directors of

Health Systems, Inc.

Community Health Systems, Inc.,

Franklin, Tennessee

Internal Control over Financial Reporting

We have audited the internal control over financial reporting of Community Health Systems, Inc., and

subsidiaries (the Company) as of December 31, 2019, based on criteria established in Internal Control Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission

In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2019, based on criteria established in Internal Control Integrated Framework

(2013) issued by COSO.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States)

(PCAOB), the consolidated financial statements and financial statement schedule as of and for the year ended December 31, 2019, of the Company and our reports dated February 20, 2020, expressed an unqualified opinion on those financial

statements and schedule and included an explanatory paragraph regarding the Companys adoption of Accounting Standards Codification Topic 842, Leases.

Opinion on Internal Control over Financial Reporting

We have audited the internal control over financial reporting of Community Health Systems, Inc., and subsidiaries (the “Company”) as of December 31, 2020, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2020, based on criteria established in Internal Control — Integrated Framework (2013) issued by COSO.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements as of and for the year ended December 31, 2020, of the Company and our report dated February 18, 2021, expressed an unqualified opinion on those financial statements.

Basis for Opinion

The Companys management is

responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Managements Report on Internal Control

over Financial Reporting .

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s report on Internal Control over Financial Reporting .

Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit.

We are a public accounting firm registered with the PCAOB and are required to be

independent with respect to the Company in accordance with the U.S.

We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S.

federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB.

Those standards require that we plan and perform the audit to obtain reasonable

assurance about whether effective internal control over financial reporting was maintained in all material respects.

Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material

weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances.

We believe that our audit provides a

reasonable basis for our opinion.

Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.

Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances.

We believe that our audit provides a reasonable basis for our opinion.

Definition and Limitations of Internal Control over Financial Reporting

A companys internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial

reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.

A companys internal control over financial reporting includes those policies and procedures that

(1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company;

(2) provide reasonable assurance that transactions are recorded as

necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors

of the company;

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.

A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company;

(2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company;

and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect

misstatements.

Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.

/s/ Deloitte & Touche LLP

2 unchanged sentences

Directors, Executive Officers and Corporate Governance

The Company has adopted a Code of Conduct that is applicable to all members of the Board of Directors and our officers, as well as employees

of our subsidiaries.

The Company has adopted a Code of Conduct that is applicable to all members of the Board of Directors and our officers, as well as employees of our subsidiaries.

A copy of the current version of our Code of Conduct is available in the Company-Overview — Corporate Governance section of our internet website at www.chs.net/company-overview/corporate-governance.

A copy of the Code of

Conduct is also available in print, free of charge, to any stockholder who requests it by writing to Community Health Systems, Inc., Investor Relations, at 4000 Meridian Boulevard, Franklin, TN 37067.

The Company intends to post amendments to or

waivers, if any, from its Code of Conduct at this location on its website, in each case to the extent such amendment or waiver would otherwise require the filing of a Current Report on Form 8-K pursuant to

Item 5.05 thereof.

A copy of the Code of Conduct is also available in print, free of charge, to any stockholder who requests it by writing to Community Health Systems, Inc., Investor Relations, at 4000 Meridian Boulevard, Franklin, TN 37067.

The Company intends to post amendments to or waivers, if any, from its Code of Conduct at this location on its website, in each case to the extent such amendment or waiver would otherwise require the filing of a Current Report on Form 8-K pursuant to Item 5.05 thereof.

The committee report of the Audit and Compliance Committee of the Board of Directors is presented below.

information required by this Item is incorporated herein by reference to the Companys definitive proxy statement to be filed under Regulation 14A in connection with the Annual Meeting of the Stockholders of the Company scheduled to be held on

May 12, 2020, under General Information, Members of the Board of Directors, Information About our Executive Officers, and, if applicable, Delinquent Section 16(a) Reports.

The other information required by this Item is incorporated herein by reference to the Company’s definitive proxy statement to be filed under Regulation 14A in connection with the Annual Meeting of the Stockholders of the Company scheduled to be held on May 11, 2021, under “General Information,” “Members of the Board of Directors,” “Information About Our Executive Officers,” and, if applicable, “Delinquent Section 16(a) Reports.”

AUDIT AND COMPLIANCE COMMITTEE REPORT

The Audit and Compliance Committee of the Board of Directors of the Company is composed of four directors, each of whom is

independent as defined by the applicable listing standards of the New York Stock Exchange and Section 10A-3 of the Exchange Act.

All of our Audit and Compliance Committee members meet the

Securities and Exchange Commission definition of audit committee financial expert. The Audit and Compliance Committee operates under a written charter adopted by the Board of Directors, which is posted on our corporate website

(www.chs.net) and which is reviewed by the Committee annually, in conjunction with the Committees annual self-evaluation.

The Audit and Compliance Committee of the Board of Directors of the Company is composed of five directors, each of whom is “independent” as defined by the applicable listing standards of the New York Stock Exchange and Section 10A-3 of the Exchange Act.

All of our Audit and Compliance Committee members meet the Securities and Exchange Commission definition of “audit committee financial expert.” The Audit and Compliance Committee operates under a written charter adopted by the Board of Directors, which is posted on our corporate website (www.chs.net) and which is reviewed by the Committee annually, in conjunction with the Committee’s annual self-evaluation.

The Company’s management is responsible for its internal controls and the financial reporting process.

independent registered public accounting firm, Deloitte & Touche LLP, is responsible for performing an independent audit of our consolidated financial statements in accordance with the standards of the Public Company Accounting Oversight

Board (United States) and to issue its reports thereon.

Our independent registered public accounting firm, Deloitte & Touche LLP, is responsible for performing an independent audit of our consolidated financial statements in accordance with the standards of the Public Company Accounting Oversight Board (United States) and to issue its reports thereon.

The Audit and Compliance Committee is responsible for, among other things, monitoring and overseeing these processes, and recommending to the Board of Directors:

(i) that the audited

consolidated financial statements be included in the Companys Annual Report on Form 10-K;

and (ii) the selection of the independent registered public accounting firm to audit the consolidated

financial statements of the Company.

In keeping with that responsibility, the Audit and Compliance Committee has reviewed and discussed

the Companys audited consolidated financial statements with management and with the independent registered public accounting firm, reviewed internal controls and accounting procedures and provided oversight review of the Companys

corporate compliance program.

In addition, the Audit and Compliance Committee has discussed with the Companys independent registered public accounting firm the matters required to be discussed by the applicable requirements of the Public

Company Accounting Oversight Board.

The Audit and Compliance Committee discussed with the Companys internal auditors and

independent registered public accounting firm the overall scope and plans for their respective audits.

The Audit and Compliance Committee met with the internal auditors and the independent registered public accounting firm with and without

management present to discuss the results of their examinations, their evaluations of the Companys internal controls and the overall quality of the Companys financial reporting.

The Audit and Compliance Committee has received the written disclosures and the letter from the independent registered public accounting firm

required by applicable requirements of the Public Company Accounting Oversight Board regarding the independent accountants communications with the audit committee concerning independence.

The Audit and Compliance Committee has discussed with

the independent registered public

accounting firm its independence and also has reviewed the amount of fees paid to the independent registered accounting firm for audit and non-audit

Based on the Audit and Compliance Committees discussions with management and the independent registered public accounting

firm and the Audit and Compliance Committees review of the representations of management and the materials it received from the independent registered public accounting firm as described above, the Audit and Compliance Committee recommended to

the Board of Directors that the audited consolidated financial statements be included in the Companys Annual Report on Form 10-K for the year ended December 31, 2019 for filing with the SEC.

(i) that the audited consolidated financial statements be included in the Company’s Annual Report on Form 10-K;

and (ii) the selection of the independent registered public accounting firm to audit the consolidated financial statements of the Company.

In keeping with that responsibility, the Audit and Compliance Committee has reviewed and discussed the Company’s audited consolidated financial statements with management and with the independent registered public accounting firm, reviewed internal controls and accounting procedures and provided oversight review of the Company’s corporate compliance program.

In addition, the Audit and Compliance Committee has discussed with the Company’s independent registered public accounting firm the matters required to be discussed by the applicable requirements of the Public Company Accounting Oversight Board.

The Audit and Compliance Committee discussed with the Company’s internal auditors and independent registered public accounting firm the overall scope and plans for their respective audits.

The Audit and Compliance Committee met with the internal auditors and the independent registered public accounting firm with and without management present to discuss the results of their examinations, their evaluations of the Company’s internal controls and the overall quality of the Company’s financial reporting.

The Audit and Compliance Committee has received the written disclosures and the letter from the independent registered public accounting firm required by applicable requirements of the Public Company Accounting Oversight Board regarding the independent accountant’s communications with the audit committee concerning independence.

The Audit and Compliance Committee has discussed with the independent registered public accounting firm its independence and also has reviewed the amount of fees paid to the independent registered accounting firm for audit and non-audit services.

Based on the Audit and Compliance Committee’s discussions with management and the independent registered public accounting firm and the Audit and Compliance Committee’s review of the representations of management and the materials it received from the independent registered public accounting firm as described above, the Audit and Compliance Committee recommended to the Board of Directors that the audited consolidated financial statements be included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 for filing with the SEC.

This report is respectfully submitted by the Audit and Compliance Committee of the Board of Directors.

4 unchanged sentences

Executive Compensation

The information required by this Item is incorporated herein by reference to the Companys definitive proxy statement to be filed under

Regulation 14A in connection with the Annual Meeting of the Stockholders of the Company scheduled to be held on May 12, 2020 under Executive Compensation, Compensation Committee Interlocks and Insider Participation, Non-Management Director Compensation, and Compensation Committee Report.

The information required by this Item is incorporated herein by reference to the Company’s definitive proxy statement to be filed under Regulation 14A in connection with the Annual Meeting of the Stockholders of the Company scheduled to be held on May 11, 2021 under “Executive Compensation,” “Compensation Committee Interlocks and Insider Participation,” “Non-Management Director Compensation,” and “Compensation Committee Report.”

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

The information required by this Item is incorporated herein by reference to the Companys definitive proxy statement to be filed under

Regulation 14A in connection with the Annual Meeting of the Stockholders of the Company scheduled to be held on May 12, 2020 under Security Ownership of Certain Beneficial Owners and Management and Equity Compensation Plan

Information.

Certain Relationships and Related Transactions, and Director

The information required by this Item is incorporated herein by reference to the Companys definitive

proxy statement to be filed under Regulation 14A in connection with the Annual Meeting of the Stockholders of the Company scheduled to be held on May 12, 2020 under General Information and Relationships and Certain

Transactions Between the Company and Its Officers, Directors and 5% Beneficial Owners and Their Family Members.

The information required by this Item is incorporated herein by reference to the Company’s definitive proxy statement to be filed under Regulation 14A in connection with the Annual Meeting of the Stockholders of the Company scheduled to be held on May 11, 2021 under “Security Ownership of Certain Beneficial Owners and Management” and “Equity Compensation Plan Information.”

Certain Relationships and Related Transactions, and Director Independence

The information required by this Item is incorporated herein by reference to the Company’s definitive proxy statement to be filed under Regulation 14A in connection with the Annual Meeting of the Stockholders of the Company scheduled to be held on May 11, 2021 under “General Information” and “Relationships and Certain Transactions Between the Company and Its Officers, Directors and 5% Beneficial Owners and Their Family Members.”

Principal Accounting Fees and Services

The information required by this Item is incorporated herein by reference to the Companys definitive proxy statement to be filed under

Regulation 14A in connection with the Annual Meeting of the Stockholders of the Company scheduled to be held on May 12, 2020 under Fees Paid to Auditors and Pre-Approval of Audit and Non-Audit Services.

The information required by this Item is incorporated herein by reference to the Company’s definitive proxy statement to be filed under Regulation 14A in connection with the Annual Meeting of the Stockholders of the Company scheduled to be held on May 11, 2021 under “Fees Paid to Auditors” and “Pre-Approval of Audit and Non-Audit Services.”

Exhibits and Financial Statement Schedules

4 unchanged sentences

Financial Statement Schedules

The following financial statement schedule is filed as part of this Form 10-K at page 194 hereof:

Schedule II Valuation and Qualifying Accounts

The following financial statement schedule is included within the notes to the consolidated financial statements at page 130 hereof:

Schedule I – Condensed Financial Information of Registrant

All other schedules are omitted since the required information is not present or is not present in amounts sufficient to require submission of the schedule.

or because the information required is included in the consolidated financial statements and notes thereto.

Item 15(a) 3.

The following exhibits are either filed with this Report or incorporated herein by reference.

Agreement and Plan of Merger, dated as of July

29, 2013, by and among Health Management Associates, Inc., Community Health Systems, Inc.

and FWCT-2 Acquisition Corporation (incorporated by reference to Exhibit

2.1 to Community Health Systems, Inc.s Current Report on Form 8-K filed July 30, 2013 (No.

Amendment and Consent to Agreement and Plan of Merger, dated as of September 24, 2013, by and among Health Management Associates, Inc., Community

Health Systems, Inc.

and FWCT-2 Acquisition Corporation (incorporated by reference to Exhibit 2.1 to Community Health Systems, Inc.s Current Report on Form

8-K filed September 25, 2013 (No.

Separation and Distribution Agreement, dated April

29, 2016, by and between Community Health Systems, Inc.

and Quorum Health Corporation (incorporated by reference to Exhibit 2.1 to Community Health Systems, Inc.s Current Report on Form 8-K filed May

Tax Matters Agreement, dated April

29, 2016, by and between Community Health Systems, Inc.

and Quorum Health Corporation (incorporated by reference to Exhibit 2.2 to Community Health Systems, Inc.s Current Report on Form 8-K filed May

Employee Matters Agreement, dated April

29, 2016, by and between Community Health Systems, Inc.

and Quorum Health Corporation (incorporated by reference to Exhibit 2.3 to Community Health Systems, Inc.s Current Report on Form 8-K filed May

Amendment to the Employee Matters Agreement, effective as of April

29, 2016, by and between Community Health Systems, Inc.

and Quorum Health Corporation (incorporated by reference to Exhibit 2.1 to Community Health Systems, Inc.s Quarterly Report on Form 10-Q for the quarter

ended September 30, 2016 filed November 2, 2016 (No.

Agreement and Plan of Merger, dated as of July 29, 2013, by and among Health Management Associates, Inc., Community Health Systems, Inc.

and FWCT-2 Acquisition Corporation (incorporated by reference to Exhibit 2.1 to Community Health Systems, Inc.’s Current Report on Form 8-K filed July 30, 2013 (No.

Amendment and Consent to Agreement and Plan of Merger, dated as of September 24, 2013, by and among Health Management Associates, Inc., Community Health Systems, Inc.

and FWCT-2 Acquisition Corporation (incorporated by reference to Exhibit 2.1 to Community Health Systems, Inc.’s Current Report on Form 8-K filed September 25, 2013 (No.

Separation and Distribution Agreement, dated April 29, 2016, by and between Community Health Systems, Inc.

and Quorum Health Corporation (incorporated by reference to Exhibit 2.1 to Community Health Systems, Inc.’s Current Report on Form 8-K filed May 2, 2016 (No.

Tax Matters Agreement, dated April 29, 2016, by and between Community Health Systems, Inc.

and Quorum Health Corporation (incorporated by reference to Exhibit 2.2 to Community Health Systems, Inc.’s Current Report on Form 8-K filed May 2, 2016 (No.

Employee Matters Agreement, dated April 29, 2016, by and between Community Health Systems, Inc.

and Quorum Health Corporation (incorporated by reference to Exhibit 2.3 to Community Health Systems, Inc.’s Current Report on Form 8-K filed May 2, 2016 (No.

Amendment to the Employee Matters Agreement, effective as of April 29, 2016, by and between Community Health Systems, Inc.

and Quorum Health Corporation (incorporated by reference to Exhibit 2.1 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2016 filed November 2, 2016 (No.

Form of Restated Certificate of Incorporation of Community Health Systems, Inc.

1 unchanged sentence

4 to Community Health Systems, Inc.’s Registration Statement on Form S-1/A filed June 8, 2000 (No.

Certificate of Amendment to the Restated Certificate of Incorporation of Community Health Systems, Inc., dated May

18, 2010 (incorporated by reference to Exhibit 3.2 to Community Health Systems, Inc.s Current Report on Form 8-K filed May 20, 2010 (No.

Certificate of Amendment to the Restated Certificate of Incorporation of Community Health Systems, Inc., dated May 18, 2010 (incorporated by reference to Exhibit 3.2 to Community Health Systems, Inc.’s Current Report on Form 8-K filed May 20, 2010 (No.

Amended and Restated By-laws of Community Health Systems, Inc.

(as of December

7, 2016) (incorporated by reference to Exhibit 3.1 to Community Health Systems, Inc.s Current Report on Form 8-K filed December

12, 2016 (No.

Form of Common Stock Certificate (incorporated by reference to Exhibit

4.1 to Community Health Systems, Inc.s Quarterly Report on Form 10-Q for the quarter ended March 31, 2014 filed May 7, 2014 (No.

Description of Community Health Systems, Inc.s Common Stock

Secured Indenture relating to CHS/Community Health Systems, Inc.s 5.125% Senior Secured Notes due 2021, dated as of January

27, 2014, by and among FWCT-2 Escrow Corporation, Regions Bank, as Trustee, and Credit Suisse AG, as Collateral Agent (incorporated by reference to Exhibit

4.1 to Community Health Systems, Inc.s Current Report on Form 8-K filed January 28, 2014 (No.

Form of 5.125% Senior Secured Note due 2021 (included in Exhibit 4.3)

Secured Notes Registration Rights Agreement, dated as of January

27, 2014, by and among FWCT-2 Escrow Corporation, Merrill Lynch, Pierce, Fenner

& Smith Incorporated and Credit Suisse Securities (USA) LLC, each as a representative of the initial purchasers (incorporated by reference to Exhibit 4.5 to Community Health Systems, Inc.s Current Report on Form 8-K filed January 28, 2014 (No.

Secured Notes Registration Rights Agreement Joinder, dated as of January

27, 2014, by and among CHS/Community Health Systems, Inc., the subsidiaries party thereto, and Merrill Lynch, Pierce, Fenner

& Smith Incorporated and Credit Suisse Securities (USA) LLC, each as a representative of the initial purchasers thereto (incorporated by reference to Exhibit 4.7 to Community Health Systems, Inc.s Current Report on Form 8-K filed January 28, 2014 (No.

First Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 5.125% Senior Secured Notes due 2021, dated as of January 27,

2014, by and among CHS/Community Health Systems, Inc., the guarantors party thereto, Regions Bank, as Trustee, and Credit Suisse AG, as Collateral Agent (incorporated by reference to Exhibit 4.2 to Community Health Systems, Inc.s Current

Report on Form 8-K filed January 28, 2014 (No.

Second Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 5.125% Senior Secured Notes due 2021, dated as of June 30,

2014, by and among CHS/Community Health Systems, Inc., the guarantors party thereto, Regions Bank, as Trustee and Credit Suisse, AG, as Collateral Agent (incorporated by reference to Exhibit 4.4 to Community Health Systems, Inc.s

Quarterly Report on Form 10-Q for the quarter ended June 30, 2014 filed August 1, 2014 (No.

Third Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 5.125% Senior Secured Notes due 2021, dated as of December

1, 2014, by and among CHS/Community Health Systems, Inc., the guarantors party thereto, Regions Bank, as Trustee and Credit Suisse AG, as Collateral Agent (incorporated by reference to Exhibit 4.41 to Community Health Systems, Inc.s

Annual Report on Form 10-K for the year ended December 31, 2014 filed February 25, 2015 (No.

Fourth Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 5.125% Senior Secured Notes due 2021, dated as of March 31,

2015, by and among CHS/Community Health Systems, Inc., the guarantors party thereto, Regions Bank, as Trustee and Credit Suisse AG, as Collateral Agent (incorporated by reference to Exhibit 4.4 to Community Health Systems, Inc.s Quarterly

Report on Form 10-Q for the quarter ended March 31, 2015 filed May 6, 2015 (No.

Fifth Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 5.125% Senior Secured Notes due 2021, dated as of June 30,

Report on Form 10-Q for the quarter ended June 30, 2015 filed August 4, 2015 (No.

Sixth Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 5.125% Senior Secured Notes due 2021, dated as of September

30, 2015, by and among CHS/Community Health Systems, Inc., the guarantors party thereto, Regions Bank, as Trustee and Credit Suisse AG, as Collateral Agent (incorporated by reference to Exhibit 4.4 to Community Health Systems, Inc.s Quarterly

Report on Form 10-Q for the quarter ended September 30, 2015 filed November 3, 2015 (No.

Seventh Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 5.125% Senior Secured Notes due 2021, dated as of December

31, 2015, by and among CHS/Community Health Systems, Inc., the guarantors party thereto, Regions Bank, as Trustee and Credit Suisse AG, as Collateral Agent (incorporated by reference to Exhibit 4.54 to Community Health Systems, Inc.s Annual

Report on Form 10-K for the year ended December 31, 2015 filed February 17, 2016 (No.

Eighth Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 5.125% Senior Secured Notes due 2021, dated as of March 31,

2016, by and among CHS/Community Health Systems, Inc., the guarantors party thereto, Regions Bank, as Trustee and Credit Suisse AG, as Collateral Agent (incorporated by reference to Exhibit 4.4 to Community Health Systems, Inc.s Quarterly

Report on Form 10-Q for the quarter ended March 31, 2016 filed May 3, 2016 (No.

Ninth Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 5.125% Senior Secured Notes due 2021, dated as of September

30, 2016, by and among CHS/Community Health Systems, Inc., the guarantors party thereto, Regions Bank, as Trustee and Credit Suisse AG, as Collateral Agent (incorporated by reference to Exhibit 4.4 to Community Health Systems, Inc.s Quarterly

Report on Form 10-Q for the quarter ended September 30, 2016 filed November 2, 2016 (No.

Tenth Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 5.125% Senior Secured Notes due 2021, dated as of April 12,

2018, by and among CHS/Community Health Systems, Inc., the guarantors party thereto, Regions Bank, as Trustee and Credit Suisse AG, as Collateral Agent (incorporated by reference to Exhibit 4.3 to Community Health Systems, Inc.s Quarterly

Report on Form 10-Q for the quarter ended March 31, 2018 filed May 2, 2018 (No.

Eleventh Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 5.125% Senior Secured Notes due 2021, dated as of October 3,

Report on Form 10-Q for the quarter ended September 30, 2018 filed October 30, 2018 (No.

Twelfth Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 5.125% Senior Secured Notes due 2021, dated as of March 31,

2019, by and among CHS/Community Health Systems, Inc., the guarantors party thereto, Regions Bank, as Trustee and Credit Suisse AG, as Collateral Agent (incorporated by reference to Exhibit 4.3 to Community Health Systems, Inc.s Quarterly

Report on Form 10-Q for the quarter ended March 31, 2019 filed May 1, 2019 (No.

Thirteenth Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 5.125% Senior Secured Notes due 2021, dated as of July 1,

Report on Form 10-Q for the quarter ended September 30, 2019 filed October 30, 2019 (No.

Fourteenth Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 5.125% Senior Secured Notes due 2021, dated as of September 27,

Report on Form 10-Q for the quarter ended September 30, 2019 filed October 30, 2019 (No.

Senior Notes Indenture relating to CHS/Community Health Systems, Inc.s 6.875% Senior Notes due 2022, dated as of January

27, 2014, by and among FWCT-2 Escrow Corporation and Regions Bank, as Trustee (incorporated by reference to Exhibit 4.3 to Community Health Systems, Inc.s Current Report on Form 8-K filed January 28, 2014 (No.

(as of December 7, 2016) (incorporated by reference to Exhibit 3.1 to Community Health Systems, Inc.’s Current Report on Form 8-K filed December 12, 2016 (No.

Form of Common Stock Certificate (incorporated by reference to Exhibit 4.1 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2014 filed May 7, 2014 (No.

Description of Community Health System, Inc.’s Common Stock (incorporated by reference to Exhibit 4.2 to Community Health Systems, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2019 filed February 20, 2020 (No.

Senior Notes Indenture relating to CHS/Community Health Systems, Inc.’s 6.875% Senior Notes due 2022, dated as of January 27, 2014, by and among FWCT-2 Escrow Corporation and Regions Bank, as Trustee (incorporated by reference to Exhibit 4.3 to Community Health Systems, Inc.’s Current Report on Form 8-K filed January 28, 2014 (No.

Form of 6.875% Senior Note due 2022 (included in Exhibit 4.3)

Unsecured Notes Registration Rights Agreement, dated as of January

27, 2014, by and among FWCT-2 Escrow Corporation, Merrill Lynch, Pierce, Fenner

& Smith Incorporated and Credit Suisse Securities (USA) LLC, each as a representative of the initial purchasers (incorporated by reference to Exhibit 4.6 to Community Health Systems, Inc.s Current Report on Form 8-K filed January 28, 2014 (No.

Unsecured Notes Registration Rights Agreement Joinder, dated as of January 27, 2014, by and among CHS/Community Health Systems, Inc., the subsidiaries

party thereto, and Merrill Lynch, Pierce, Fenner & Smith Incorporated and Credit Suisse Securities (USA) LLC, each as a representative of the initial purchasers (incorporated by reference to Exhibit 4.8 to Community Health Systems,

Inc.s Current Report on Form 8-K filed January 28, 2014 (No.

First Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 6.875% Senior Notes due 2022, dated as of January

27, 2014, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee (incorporated by reference to Exhibit 4.4 to Community Health Systems, Inc.s Current Report on Form 8-K filed January 28, 2014 (No.

Second Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 6.875% Senior Notes due 2022, dated as of June

30, 2014, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee (incorporated by reference to Exhibit 4.5 to Community Health Systems, Inc.s Quarterly Report on Form 10-Q for the quarter ended June 30, 2014 filed August 1, 2014 (No.

Third Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 6.875% Senior Notes due 2022, dated as of December

1, 2014, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee (incorporated by reference to Exhibit 4.46 to Community Health Systems, Inc.s Annual Report on Form 10-K for the year ended December 31, 2014 filed February 25, 2015 (No.

Fourth Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 6.875% Senior Notes due 2022, dated as of March

31, 2015, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee (incorporated by reference to Exhibit 4.5 to Community Health Systems, Inc.s Quarterly Report on Form 10-Q for the quarter ended March 31, 2015 filed May 6, 2015 (No.

Fifth Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 6.875% Senior Notes due 2022, dated as of June

30, 2015, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee (incorporated by reference to Exhibit 4.5 to Community Health Systems, Inc.s Quarterly Report on Form 10-Q for the quarter ended June 30, 2015 filed August 4, 2015 (No.

Sixth Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 6.875% Senior Notes due 2022, dated as of September

Seventh Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 6.875% Senior Notes due 2022, dated as of December 31,

2015, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee (incorporated by reference to Exhibit 4.63 to Community Health Systems, Inc.s Annual Report on Form 10-K for the year ended December 31, 2015 filed February 17, 2016 (No.

Eighth Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 6.875% Senior Notes due 2022, dated as of March

31, 2016, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee (incorporated by reference to Exhibit 4.5 to Community Health Systems, Inc.s Quarterly Report on Form 10-Q for the quarter ended March 31, 2016 filed May 3, 2016 (No.

Ninth Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 6.875% Senior Notes due 2022, dated as of September

30, 2016, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee (incorporated by reference to Exhibit 4.5 to Community Health Systems, Inc.s Quarterly Report on Form 10-Q for the quarter ended September 30, 2016 filed November 2, 2016 (No.

Tenth Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 6.875% Senior Notes due 2022, dated as of April

12, 2018, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee (incorporated by reference to Exhibit 4.4 to Community Health Systems, Inc.s Quarterly Report on Form 10-Q for the quarter ended March 31, 2018 filed May 2, 2018 (No.

Eleventh Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 6.875% Senior Notes due 2022, dated as of October 3,

2018, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee (incorporated by reference to Exhibit 4.4 to Community Health Systems, Inc.s Quarterly Report on Form 10-Q for the quarter ended September 30, 2018 filed October 30, 2018 (No.

Twelfth Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 6.875% Senior Notes due 2022, dated as of March

31, 2019, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee (incorporated by reference to Exhibit 4.4 to Community Health Systems, Inc.s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019 filed May 1, 2019 (No.

Thirteenth Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 6.875% Senior Notes due 2022, dated as of July

1, 2019, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee (incorporated by reference to Exhibit 4.4 to Community Health Systems, Inc.s Quarterly Report on Form 10-Q for the quarter ended September 30, 2019 filed October 30, 2019 (No.

Fourteenth Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 6.875% Senior Notes due 2022, dated as of September 27,

2019, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee (incorporated by reference to Exhibit 4.13 to Community Health Systems, Inc.s Quarterly Report on Form 10-Q for the quarter ended September 30, 2019 filed October 30, 2019 (No.

Senior Secured Notes Indenture relating to CHS/Community Health Systems, Inc.s 6.250% Senior Secured Notes due 2023, dated as of March 16,

2017, by and among CHS/Community Health Systems, Inc.

and Regions Bank, as Trustee (incorporated by reference to Exhibit 4.1 to Community Health Systems, Inc.s Current Report on Form 8-K filed

March 16, 2017 (No.

Unsecured Notes Registration Rights Agreement, dated as of January 27, 2014, by and among FWCT-2 Escrow Corporation, Merrill Lynch, Pierce, Fenner & Smith Incorporated and Credit Suisse Securities (USA) LLC, each as a representative of the initial purchasers (incorporated by reference to Exhibit 4.6 to Community Health Systems, Inc.’s Current Report on Form 8-K filed January 28, 2014 (No.

Unsecured Notes Registration Rights Agreement Joinder, dated as of January 27, 2014, by and among CHS/Community Health Systems, Inc., the subsidiaries party thereto, and Merrill Lynch, Pierce, Fenner & Smith Incorporated and Credit Suisse Securities (USA) LLC, each as a representative of the initial purchasers (incorporated by reference to Exhibit 4.8 to Community Health Systems, Inc.’s Current Report on Form 8-K filed January 28, 2014 (No.

First Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 6.875% Senior Notes due 2022, dated as of January 27, 2014, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee (incorporated by reference to Exhibit 4.4 to Community Health Systems, Inc.’s Current Report on Form 8-K filed January 28, 2014 (No.

Second Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 6.875% Senior Notes due 2022, dated as of June 30, 2014, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee (incorporated by reference to Exhibit 4.5 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2014 filed August 1, 2014 (No.

Third Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 6.875% Senior Notes due 2022, dated as of December 1, 2014, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee (incorporated by reference to Exhibit 4.46 to Community Health Systems, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2014 filed February 25, 2015 (No.

Fourth Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 6.875% Senior Notes due 2022, dated as of March 31, 2015, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee (incorporated by reference to Exhibit 4.5 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2015 filed May 6, 2015 (No.

Fifth Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 6.875% Senior Notes due 2022, dated as of June 30, 2015, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee (incorporated by reference to Exhibit 4.5 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2015 filed August 4, 2015 (No.

Sixth Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 6.875% Senior Notes due 2022, dated as of September 30, 2015, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee (incorporated by reference to Exhibit 4.5 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2015 filed November 3, 2015 (No.

Seventh Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 6.875% Senior Notes due 2022, dated as of December 31, 2015, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee (incorporated by reference to Exhibit 4.63 to Community Health Systems, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2015 filed February 17, 2016 (No.

Eighth Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 6.875% Senior Notes due 2022, dated as of March 31, 2016, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee (incorporated by reference to Exhibit 4.5 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2016 filed May 3, 2016 (No.

Ninth Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 6.875% Senior Notes due 2022, dated as of September 30, 2016, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee (incorporated by reference to Exhibit 4.5 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2016 filed November 2, 2016 (No.

Tenth Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 6.875% Senior Notes due 2022, dated as of April 12, 2018, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee (incorporated by reference to Exhibit 4.4 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2018 filed May 2, 2018 (No.

Eleventh Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 6.875% Senior Notes due 2022, dated as of October 3, 2018, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee (incorporated by reference to Exhibit 4.4 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2018 filed October 30, 2018 (No.

Twelfth Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 6.875% Senior Notes due 2022, dated as of March 31, 2019, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee (incorporated by reference to Exhibit 4.4 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019 filed May 1, 2019 (No.

Thirteenth Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 6.875% Senior Notes due 2022, dated as of July 1, 2019, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee (incorporated by reference to Exhibit 4.4 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2019 filed October 30, 2019 (No.

Fourteenth Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 6.875% Senior Notes due 2022, dated as of September 27, 2019, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee (incorporated by reference to Exhibit 4.13 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2019 filed October 30, 2019 (No.

Fifteenth Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 6.875% Senior Notes due 2022, dated as of March 27, 2020, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee (incorporated by reference to Exhibit 4.3 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2020 filed April 29, 2020 (No.

Sixteenth Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 6.875% Senior Notes due 2022, dated as of December 11, 2020, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee

Senior Secured Notes Indenture relating to CHS/Community Health Systems, Inc.’s 6.250% Senior Secured Notes due 2023, dated as of March 16, 2017, by and among CHS/Community Health Systems, Inc.

and Regions Bank, as Trustee (incorporated by reference to Exhibit 4.1 to Community Health Systems, Inc.’s Current Report on Form 8-K filed March 16, 2017 (No.

Form of 6.250% Senior Secured Note due 2023 (included in Exhibit 4.23)

First Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 6.250% Senior Secured Notes due 2023, dated March

16, 2017, by and among CHS/Community Health Systems, Inc., Community Health Systems, Inc., the Guarantors party thereto, Regions Bank, as Trustee, and Credit Suisse AG, as collateral agent (incorporated by reference to Exhibit

4.1 to Community Health Systems, Inc.s Current Report on Form 8-K filed March 16, 2017 (No.

Second Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 6.250% Senior Secured Notes due 2023, dated May

12, 2017, by and among CHS/Community Health Systems, Inc., Community Health Systems, Inc., the Guarantors party thereto, Regions Bank, as Trustee, and Credit Suisse AG, as collateral agent (incorporated by reference to Exhibit

4.3 to Community Health Systems, Inc.s Current Report on Form 8-K filed May 12, 2017 (No.

Third Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 6.250% Senior Secured Notes due 2023, dated as of April 12,

Report on Form 10-Q for the quarter ended March 31, 2018 filed May 2, 2018 (No.

Fourth Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 6.250% Senior Secured Notes due 2023, dated as of October 3,

2018, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee and Credit Suisse AG, as Collateral Agent (incorporated by reference to Exhibit 4.5 to Community Health Systems, Inc.s Quarterly

Report on Form 10-Q for the quarter ended September 30, 2018 filed October 30, 2018 (No.

Fifth Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 6.250% Senior Secured Notes due 2023, dated as of March 31,

2019, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee and Credit Suisse AG, as Collateral Agent (incorporated by reference to Exhibit 4.5 to Community Health Systems, Inc.s Quarterly

Report on Form 10-Q for the quarter ended March 31, 2019 filed May 1, 2019 (No.

Sixth Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 6.250% Senior Secured Notes due 2023, dated as of July 1,

Report on Form 10-Q for the quarter ended September 30, 2019 filed October 30, 2019 (No.

Seventh Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 6.250% Senior Secured Notes due 2023, dated as of September 27,

Report on Form 10-Q for the quarter ended September 30, 2019 filed October 30, 2019 (No.

Indenture, dated as of June 22, 2018, among CHS/Community Health Systems, Inc., Community Health Systems, Inc., the guarantors party thereto,

Regions Bank, as Trustee and as Junior-Priority Collateral Agent, relating to the 9.875% Junior-Priority Secured Notes due 2023 (incorporated by reference to Exhibit 4.01 to Community Health Systems, Inc.s Current Report on Form 8-K filed June 25, 2018 (No.

First Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 6.250% Senior Secured Notes due 2023, dated March 16, 2017, by and among CHS/Community Health Systems, Inc., Community Health Systems, Inc., the Guarantors party thereto, Regions Bank, as Trustee, and Credit Suisse AG, as Collateral Agent (incorporated by reference to Exhibit 4.2 to Community Health Systems, Inc.’s Current Report on Form 8-K filed March 16, 2017 (No.

Second Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 6.250% Senior Secured Notes due 2023, dated May 12, 2017, by and among CHS/Community Health Systems, Inc., Community Health Systems, Inc., the Guarantors party thereto, Regions Bank, as Trustee, and Credit Suisse AG, as Collateral Agent (incorporated by reference to Exhibit 4.3 to Community Health Systems, Inc.’s Current Report on Form 8-K filed May 12, 2017 (No.

Third Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 6.250% Senior Secured Notes due 2023, dated as of April 12, 2018, by and among CHS/Community Health Systems, Inc., the guarantors party thereto, Regions Bank, as Trustee and Credit Suisse AG, as Collateral Agent (incorporated by reference to Exhibit 4.5 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2018 filed May 2, 2018 (No.

Fourth Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 6.250% Senior Secured Notes due 2023, dated as of October 3, 2018, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee and Credit Suisse AG, as Collateral Agent (incorporated by reference to Exhibit 4.5 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2018 filed October 30, 2018 (No.

Fifth Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 6.250% Senior Secured Notes due 2023, dated as of March 31, 2019, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee and Credit Suisse AG, as Collateral Agent (incorporated by reference to Exhibit 4.5 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019 filed May 1, 2019 (No.

Sixth Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 6.250% Senior Secured Notes due 2023, dated as of July 1, 2019, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee and Credit Suisse AG, as Collateral Agent (incorporated by reference to Exhibit 4.5 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2019 filed October 30, 2019 (No.

Seventh Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 6.250% Senior Secured Notes due 2023, dated as of September 27, 2019, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee and Credit Suisse AG, as Collateral Agent (incorporated by reference to Exhibit 4.14 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2019 filed October 30, 2019 (No.

Eighth Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 6.250% Senior Secured Notes due 2023, dated as of March 27, 2020, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee and Credit Suisse AG, as Collateral Agent (incorporated by reference to Exhibit 4.4 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2020 filed April 29, 2020 (No.

Ninth Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 6.250% Senior Secured Notes due 2023, dated as of December 11, 2020, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee and Credit Suisse AG, as Collateral Agent

Indenture, dated as of June 22, 2018, among CHS/Community Health Systems, Inc., Community Health Systems, Inc., the guarantors party thereto, Regions Bank, as Trustee and as Junior-Priority Collateral Agent, relating to the 9.875% Junior-Priority Secured Notes due 2023 (incorporated by reference to Exhibit 4.01 to Community Health Systems, Inc.'s Current Report on Form 8-K filed June 25, 2018 (No.

Form of 9.875% Junior-Priority Secured Note due 2023 (included in Exhibit 4.34)

First Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 9.875% Junior-Priority Secured Notes due 2023, dated as of

October 3, 2018, by and among CHS/Community Health Systems, Inc., the guarantors party thereto, and Regions Bank, as Trustee and as Junior-Priority Collateral Agent (incorporated by reference to Exhibit 4.6 to Community Health Systems,

Inc.s Quarterly Report on Form 10-Q for the quarter ended September 30, 2018 filed October 30, 2018 (No.

Second Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 9.875% Junior-Priority Secured Notes due 2023, dated as of

March 31, 2019, by and among CHS/Community Health Systems, Inc., the guarantors party thereto, and Regions Bank, as Trustee and as Junior-Priority Collateral Agent (incorporated by reference to Exhibit 4.6 to Community Health Systems,

Inc.s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019 filed May 1, 2019 (No.

Third Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 9.875% Junior-Priority Secured Notes due 2023, dated as of

July 1, 2019, by and among CHS/Community Health Systems, Inc., the guarantors party thereto, and Regions Bank, as Trustee and as Junior-Priority Collateral Agent (incorporated by reference to Exhibit 4.6 to Community Health Systems,

Inc.s Quarterly Report on Form 10-Q for the quarter ended September 30, 2019 filed October 30, 2019 (No.

Fourth Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 9.875% Junior-Priority Secured Notes due 2023, dated as of

September 27, 2019, by and among CHS/Community Health Systems, Inc., the guarantors party thereto, and Regions Bank, as Trustee and as Junior-Priority Collateral Agent (incorporated by reference to Exhibit 4.15 to Community Health Systems,

Inc.s Quarterly Report on Form 10-Q for the quarter ended September 30, 2019 filed October 30, 2019 (No.

Indenture, dated as of June 22, 2018, among CHS/Community Health Systems, Inc., Community Health Systems, Inc., the guarantors party thereto,

Regions Bank, as Trustee and as Junior-Priority Collateral Agent, relating to the 8.125% Junior-Priority Secured Notes due 2024 (incorporated by reference to Exhibit 4.02 to Community Health Systems, Inc.s Current Report on Form 8-K filed June 25, 2018 (No.

First Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 9.875% Junior-Priority Secured Notes due 2023, dated as of October 3, 2018, by and among CHS/Community Health Systems, Inc., the guarantors party thereto, and Regions Bank, as Trustee and as Junior-Priority Collateral Agent (incorporated by reference to Exhibit 4.6 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2018 filed October 30, 2018 (No.

Second Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 9.875% Junior-Priority Secured Notes due 2023, dated as of March 31, 2019, by and among CHS/Community Health Systems, Inc., the guarantors party thereto, and Regions Bank, as Trustee and as Junior-Priority Collateral Agent (incorporated by reference to Exhibit 4.6 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019 filed May 1, 2019 (No.

Third Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 9.875% Junior-Priority Secured Notes due 2023, dated as of July 1, 2019, by and among CHS/Community Health Systems, Inc., the guarantors party thereto, and Regions Bank, as Trustee and as Junior-Priority Collateral Agent (incorporated by reference to Exhibit 4.6 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2019 filed October 30, 2019 (No.

Fourth Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 9.875% Junior-Priority Secured Notes due 2023, dated as of September 27, 2019, by and among CHS/Community Health Systems, Inc., the guarantors party thereto, and Regions Bank, as Trustee and as Junior-Priority Collateral Agent (incorporated by reference to Exhibit 4.15 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2019 filed October 30, 2019 (No.

Fifth Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 9.875% Junior-Priority Secured Notes due 2023, dated as of March 27, 2020, by and among CHS/Community Health Systems, Inc., the guarantors party thereto, and Regions Bank, as Trustee and as Junior-Priority Collateral Agent (incorporated by reference to Exhibit 4.5 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2020 filed April 29, 2020 (No.

Sixth Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 9.875% Junior-Priority Secured Notes due 2023, dated as of December 11, 2020, by and among CHS/Community Health Systems, Inc., the guarantors party thereto, and Regions Bank, as Trustee and as Junior-Priority Collateral Agent

Indenture, dated as of June 22, 2018, among CHS/Community Health Systems, Inc., Community Health Systems, Inc., the guarantors party thereto, Regions Bank, as Trustee and as Junior-Priority Collateral Agent, relating to the 8.125% Junior-Priority Secured Notes due 2024 (incorporated by reference to Exhibit 4.02 to Community Health Systems, Inc.'s Current Report on Form 8-K filed June 25, 2018 (No.

Form of 8.125% Junior-Priority Secured Note due 2024 (included in Exhibit 4.42)

First Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 8.125% Junior-Priority Secured Notes due 2024, dated as of

Inc.s Quarterly Report on Form 10-Q for the quarter ended September 30, 2018 filed October 30, 2018 (No.

Second Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 8.125% Junior-Priority Secured Notes due 2024, dated as of

Inc.s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019 filed May 1, 2019 (No.

Third Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 8.125% Junior-Priority Secured Notes due 2024, dated as of

Inc.s Quarterly Report on Form 10-Q for the quarter ended September 30, 2019 filed October 30, 2019 (No.

Fourth Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 8.125% Junior-Priority Secured Notes due 2024, dated as of

Inc.s Quarterly Report on Form 10-Q for the quarter ended September 30, 2019 filed October 30, 2019 (No.

Indenture, dated as of July 6, 2018, among CHS/Community Health Systems, Inc., Community Health Systems, Inc., the guarantors party thereto, Regions

Bank, as trustee, and Credit Suisse AG, as collateral agent, relating to the 8.625% Senior Secured Notes due 2024 (incorporated by reference to Exhibit 4.1 to Community Health Systems, Inc.s Current Report on Form 8-K filed July 6, 2018 (No.

First Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 8.125% Junior-Priority Secured Notes due 2024, dated as of October 3, 2018, by and among CHS/Community Health Systems, Inc., the guarantors party thereto, and Regions Bank, as Trustee and as Junior-Priority Collateral Agent (incorporated by reference to Exhibit 4.7 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2018 filed October 30, 2018 (No.

Second Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 8.125% Junior-Priority Secured Notes due 2024, dated as of March 31, 2019, by and among CHS/Community Health Systems, Inc., the guarantors party thereto, and Regions Bank, as Trustee and as Junior-Priority Collateral Agent (incorporated by reference to Exhibit 4.7 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019 filed May 1, 2019 (No.

Third Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 8.125% Junior-Priority Secured Notes due 2024, dated as of July 1, 2019, by and among CHS/Community Health Systems, Inc., the guarantors party thereto, and Regions Bank, as Trustee and as Junior-Priority Collateral Agent (incorporated by reference to Exhibit 4.7 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2019 filed October 30, 2019 (No.

Fourth Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 8.125% Junior-Priority Secured Notes due 2024, dated as of September 27, 2019, by and among CHS/Community Health Systems, Inc., the guarantors party thereto, and Regions Bank, as Trustee and as Junior-Priority Collateral Agent (incorporated by reference to Exhibit 4.16 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2019 filed October 30, 2019 (No.

Fifth Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 8.125% Junior-Priority Secured Notes due 2024, dated as of March 27, 2020, by and among CHS/Community Health Systems, Inc., the guarantors party thereto, and Regions Bank, as Trustee and as Junior-Priority Collateral Agent (incorporated by reference to Exhibit 4.6 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2020 filed April 29, 2020 (No.

Sixth Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 8.125% Junior-Priority Secured Notes due 2024, dated as of December 11, 2020, by and among CHS/Community Health Systems, Inc., the guarantors party thereto, and Regions Bank, as Trustee and as Junior-Priority Collateral Agent

Indenture, dated as of July 6, 2018, among CHS/Community Health Systems, Inc., Community Health Systems, Inc., the guarantors party thereto, Regions Bank, as Trustee, and Credit Suisse AG, as Collateral Agent, relating to the 8.625% Senior Secured Notes due 2024 (incorporated by reference to Exhibit 4.1 to Community Health Systems, Inc.'s Current Report on Form 8-K filed July 6, 2018 (No.

Form of 8.625% Senior Secured Note due 2024 (included in Exhibit 4.50)

First Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 8.625% Senior Secured Notes due 2024, dated as of October 3,

Report on Form 10-Q for the quarter ended September 30, 2018 filed October 30, 2018 (No.

Second Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 8.625% Senior Secured Notes due 2024, dated as of March 31,

Report on Form 10-Q for the quarter ended March 31, 2019 filed May 1, 2019 (No.

Third Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 8.625% Senior Secured Notes due 2024, dated as of July 1,

Report on Form 10-Q for the quarter ended September 30, 2019 filed October 30, 2019 (No.

Fourth Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 8.625% Senior Secured Notes due 2024, dated as of September 27,

Report on Form 10-Q for the quarter ended September 30, 2019 filed October 30, 2019 (No.

Indenture, dated as of March

6, 2019, among CHS/Community Health Systems, Inc., Community Health Systems, Inc., the guarantors party thereto, Regions Bank, as trustee, and Credit Suisse AG, as Collateral Agent, relating to the 8.000% Senior Secured Notes due 2026 (incorporated by reference

to Exhibit 4.1 to Community Health Systems, Inc.s Current Report on Form 8-K filed March 6, 2019 (No.

First Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 8.625% Senior Secured Notes due 2024, dated as of October 3, 2018, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee and Credit Suisse AG, as Collateral Agent (incorporated by reference to Exhibit 4.8 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2018 filed October 30, 2018 (No.

Second Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 8.625% Senior Secured Notes due 2024, dated as of March 31, 2019, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee and Credit Suisse AG, as Collateral Agent (incorporated by reference to Exhibit 4.8 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019 filed May 1, 2019 (No.

Third Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 8.625% Senior Secured Notes due 2024, dated as of July 1, 2019, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee and Credit Suisse AG, as Collateral Agent (incorporated by reference to Exhibit 4.8 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2019 filed October 30, 2019 (No.

Fourth Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 8.625% Senior Secured Notes due 2024, dated as of September 27, 2019, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee and Credit Suisse AG, as Collateral Agent (incorporated by reference to Exhibit 4.17 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2019 filed October 30, 2019 (No.

Fifth Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 8.625% Senior Secured Notes due 2024, dated as of March 27, 2020, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee and Credit Suisse AG, as Collateral Agent (incorporated by reference to Exhibit 4.7 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2020 filed April 29, 2020 (No.

Sixth Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 8.625% Senior Secured Notes due 2024, dated as of December 11, 2020, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee and Credit Suisse AG, as Collateral Agent

Indenture, dated as of March 6, 2019, among CHS/Community Health Systems, Inc., Community Health Systems, Inc., the guarantors party thereto, Regions Bank, as Trustee, and Credit Suisse AG, as Collateral Agent, relating to the 8.000% Senior Secured Notes due 2026 (incorporated by reference to Exhibit 4.1 to Community Health Systems, Inc.'s Current Report on Form 8-K filed March 6, 2019 (No.

Form of 8.000% Senior Secured Note due 2026 (included in Exhibit 4.58)

First Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 8.000% Senior Secured Notes due 2026, dated as of March 31,

Report on Form 10-Q for the quarter ended March 31, 2019 filed May 1, 2019 (No.

Second Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 8.000% Senior Secured Notes due 2026, dated as of July 1,

Report on Form 10-Q for the quarter ended September 30, 2019 filed October 30, 2019 (No.

Third Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 8.000% Senior Secured Notes due 2026, dated as of September 27,

Report on Form 10-Q for the quarter ended September 30, 2019 filed October 30, 2019 (No.

Supplemental Indenture relating to CHS/Community Health Systems, Inc.s 8.000% Senior Secured Notes due 2026, dated as of November 19,

2019, by and among CHS/Community Health Systems, Inc., Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee and Credit Suisse AG, as Collateral Agent (incorporated by reference to Exhibit 4.4 to Community Health

Systems, Inc.s Current Report on Form 8-K filed November 19, 2019 (No.

Indenture, dated as of November

19, 2019, among CHS/Community Health Systems, Inc., Community Health Systems, Inc., the guarantors party thereto, Regions Bank, as Trustee, and Credit Suisse AG, as Collateral Agent, relating to the 8.000% Senior Secured Notes due 2027 (incorporated by

reference to Exhibit 4.1 to Community Health Systems, Inc.s Current Report on Form 8-K filed November 19, 2019 (No.

First Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 8.000% Senior Secured Notes due 2026, dated as of March 31, 2019, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee and Credit Suisse AG, as Collateral Agent (incorporated by reference to Exhibit 4.10 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019 filed May 1, 2019 (No.

Second Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 8.000% Senior Secured Notes due 2026, dated as of July 1, 2019, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee and Credit Suisse AG, as Collateral Agent (incorporated by reference to Exhibit 4.9 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2019 filed October 30, 2019 (No.

Third Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 8.000% Senior Secured Notes due 2026, dated as of September 27, 2019, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee and Credit Suisse AG, as Collateral Agent (incorporated by reference to Exhibit 4.18 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2019 filed October 30, 2019 (No.

Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 8.000% Senior Secured Notes due 2026, dated as of November 19, 2019, by and among CHS/Community Health Systems, Inc., Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee and Credit Suisse AG, as Collateral Agent (incorporated by reference to Exhibit 4.4 to Community Health Systems, Inc.'s Current Report on Form 8-K filed November 19, 2019 (No.

Fifth Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 8.000% Senior Secured Notes due 2026, dated as of March 27, 2020, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee and Credit Suisse AG, as Collateral Agent (incorporated by reference to Exhibit 4.8 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2020 filed April 29, 2020 (No.

Sixth Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 8.000% Senior Secured Notes due 2026, dated as of December 11, 2020, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee and Credit Suisse AG, as Collateral Agent

Indenture, dated as of November 19, 2019, among CHS/Community Health Systems, Inc., Community Health Systems, Inc., the guarantors party thereto, Regions Bank, as Trustee, and Credit Suisse AG, as Collateral Agent, relating to the 8.000% Senior Secured Notes due 2027 (incorporated by reference to Exhibit 4.1 to Community Health Systems, Inc.'s Current Report on Form 8-K filed November 19, 2019 (No.

Form of 8.000% Senior Secured Note due 2027 (included in Exhibit 4.66)

Indenture, dated as of November

19, 2019, among CHS/Community Health Systems, Inc., Community Health Systems, Inc., the guarantors party thereto, and Regions Bank, as Trustee, relating to the 6.875% Senior Unsecured Notes due 2028 (incorporated by reference to Exhibit 4.2 to Community

Health Systems, Inc.s Current Report on Form 8-K filed November 19, 2019 (No.

First Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 8.000% Senior Secured Notes due 2027, dated as of March 27, 2020, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee and Credit Suisse AG, as Collateral Agent (incorporated by reference to Exhibit 4.9 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2020 filed April 29, 2020 (No.

Second Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 8.000% Senior Secured Notes due 2027, dated as of December 11, 2020, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee and Credit Suisse AG, as Collateral Agent

Indenture, dated as of November 19, 2019, among CHS/Community Health Systems, Inc., Community Health Systems, Inc., the guarantors party thereto, and Regions Bank, as Trustee, relating to the 6.875% Senior Unsecured Notes due 2028 (incorporated by reference to Exhibit 4.2 to Community Health Systems, Inc.'s Current Report on Form 8-K filed November 19, 2019 (No.

Form of 6.875% Senior Unsecured Note due 2028 (included in Exhibit 4.70)

Indenture, dated as of February

6, 2020, among CHS/Community Health Systems, Inc., Community Health Systems, Inc., the guarantors party thereto, Regions Bank, as Trustee, and Credit Suisse AG, as Collateral Agent, relating to the 6.625% Senior Secured Notes due 2025 (incorporated by reference

to Exhibit 4.1 to Community Health Systems, Inc.s Current Report on Form 8-K filed February 6, 2020 (No.

First Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 6.875% Senior Unsecured Notes due 2028, dated as of March 27, 2020, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee (incorporated by reference to Exhibit 4.10 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2020 filed April 29, 2020 (No.

Second Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 6.875% Senior Unsecured Notes due 2028, dated as of December 11, 2020, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee

Indenture, dated as of February 6, 2020, among CHS/Community Health Systems, Inc., Community Health Systems, Inc., the guarantors party thereto, Regions Bank, as Trustee, and Credit Suisse AG, as Collateral Agent, relating to the 6.625% Senior Secured Notes due 2025 (incorporated by reference to Exhibit 4.1 to Community Health Systems, Inc.'s Current Report on Form 8-K filed February 6, 2020 (No.

Form of 6.625% Senior Secured Note due 2025 (included in Exhibit 4.74)

First Lien Intercreditor Agreement, dated as of August

17, 2012, among Credit Suisse AG, as Collateral Agent, Credit Suisse AG, as authorized representative, Regions Bank, as Trustee and authorized representative, and the additional authorized representatives party thereto (incorporated by reference to Exhibit

4.2 to Community Health Systems, Inc.s Quarterly Report on Form 10-Q for the quarter ended September 30, 2012 filed November 1, 2012

Amended and Restated ABL Intercreditor Agreement, dated as of June 22, 2018, among JPMorgan Chase Bank, N.A., as ABL Agent, Credit Suisse AG,

as Senior-Priority Collateral Agent, Credit Suisse AG, as Senior-Priority Non-ABL Loan Agent, Regions Bank, as 2021 Secured Notes Trustee, 2023 Secured Notes Trustee, 2024 Secured Notes Trustee, 2025 Secured

Notes Trustee, 2026 Secured Notes Trustee, 2027 Secured Notes Trustee, Junior-Priority Collateral Agent, 2023 Junior-Priority Secured Notes Trustee and 2024 Junior-Priority Secured Notes Trustee, CHS/Community Health Systems, Inc., Community Health

Systems, Inc., the subsidiary guarantors party thereto and each additional agent from time to time party thereto (incorporated by reference to Exhibit 4.04 to Community Health Systems, Inc.s Current Report on Form 8-K filed June 25, 2018 (No.

Junior-Priority Collateral Agreement, dated as of June 22, 2018, among CHS/Community Health Systems, Inc., Community Health Systems, Inc., the

subsidiaries party thereto and Regions Bank, as junior-priority collateral agent (incorporated by reference to Exhibit 4.03 to Community Health Systems, Inc.s Current Report on Form 8-K filed

June 25, 2018 (No.

Senior-Junior Lien Intercreditor Agreement, dated as of June 22, 2018, among CHS/Community Health Systems, Inc., Community Health Systems, Inc.,

the subsidiaries party thereto, Credit Suisse AG, Cayman Islands Branch, as initial Senior-Priority Collateral Agent, Regions Bank, as initial Junior-Priority Collateral Agent and each additional agent from time to time party thereto (incorporated

by reference to Exhibit 4.05 to Community Health Systems, Inc.s Current Report on Form 8-K filed June 25, 2018 (No.

Junior-Priority Lien Pari Passu Intercreditor Agreement, dated as of June 22, 2018, among Regions Bank, as Collateral Agent, Regions Bank, in

its capacity as Trustee under the 2023 Notes Indenture, Regions Bank, in its capacity as Trustee under the 2024 Notes Indenture and each additional authorized representative from time to time party thereto (incorporated by reference to Exhibit 4.06

to Community Health Systems, Inc.s Current Report on Form 8-K filed June 25, 2018 (No.

Second Amended and Restated Guarantee and Collateral Agreement, dated as of July 25, 2007, as amended and restated as of November

5, 2010, as further amended as of August 17, 2012, and as further amended and restated as of November

19, 2019, among CHS/Community Health Systems, Inc., Community Health Systems, Inc., the subsidiary guarantors party thereto and Credit Suisse AG, as Collateral Agent (incorporated by reference to Exhibit

4.5 to Community Health Systems, Inc.s Current Report on Form 8-K filed November 19, 2019 (No.

ABL Credit Agreement, dated as of April

3, 2018, among CHS/Community Health Systems, Inc., as the Borrower, Community Health Systems, Inc., as the Parent, the subsidiaries of the Borrower party thereto, the lenders party thereto, and JPMorgan Chase Bank, N.A., as Administrative Agent and Collateral

Agent (incorporated by reference to Exhibit 10.1 to Community Health Systems, Inc.s Current Report on Form 8-K filed April 3, 2018 (No.

First Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 6.625% Senior Secured Notes due 2025, dated as of March 27, 2020, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee and Credit Suisse AG, as Collateral Agent (incorporated by reference to Exhibit 4.11 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2020 filed April 29, 2020 (No.

Second Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 6.625% Senior Secured Notes due 2025, dated as of December 11, 2020, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and Regions Bank, as Trustee and Credit Suisse AG, as Collateral Agent

Indenture, dated as of December 28, 2020, among CHS/Community Health Systems, Inc., Community Health Systems, Inc., the guarantors party thereto, Regions Bank, as Trustee, and Credit Suisse AG, as Collateral Agent, relating to the 5.625% Senior Secured Notes due 2027 (incorporated by reference to Exhibit 4.1 to Community Health Systems, Inc.'s Current Report on Form 8-K filed December 28, 2020 (No.

Form of 5.625% Senior Secured Note due 2027 (included in Exhibit 4.78)

Indenture, dated as of December 28, 2020, among CHS/Community Health Systems, Inc., Community Health Systems, Inc., the guarantors party thereto, Regions Bank, as Trustee, and Credit Suisse AG, as Collateral Agent, relating to the 6.000% Senior Secured Notes due 2029 (incorporated by reference to Exhibit 4.2 to Community Health Systems, Inc.'s Current Report on Form 8-K filed December 28, 2020 (No.

Form of 6.000% Senior Secured Note due 2029 (included in Exhibit 4.80)

Indenture, dated as of February 2, 2021, among CHS/Community Health Systems, Inc., Community Health Systems, Inc., the guarantors party thereto, Regions Bank, as Trustee and Collateral Agent, relating to the 6.875% Junior-Priority Secured Notes due 2029 (incorporated by reference to Exhibit 4.1 to Community Health Systems, Inc.'s Current Report on Form 8-K filed February 2, 2021 (No.

Form of 6.875% Junior-Priority Secured Note due 2029 (included in Exhibit 4.82)

Indenture, dated as of February 9, 2021, among CHS/Community Health Systems, Inc., Community Health Systems, Inc., the guarantors party thereto, Regions Bank, as Trustee, and Credit Suisse AG, Collateral Agent, relating to the 4.750% Senior Secured Notes due 2031 (incorporated by reference to Exhibit 4.1 to Community Health Systems, Inc.'s Current Report on Form 8-K filed February 9, 2021 (No.

Form of 4.750% Senior Secured Note due 2031 (included in Exhibit 4.84)

First Lien Intercreditor Agreement, dated as of August 17, 2012, among Credit Suisse AG, as Collateral Agent, Credit Suisse AG, as authorized representative, Regions Bank, as Trustee and authorized representative, and the additional authorized representatives party thereto (incorporated by reference to Exhibit 4.2 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2012 filed November 1, 2012 (No.

Amended and Restated ABL Intercreditor Agreement, dated as of June 22, 2018, among JPMorgan Chase Bank, N.A., as ABL Agent, Credit Suisse AG, as Senior-Priority Collateral Agent, Credit Suisse AG, as Senior-Priority Non-ABL Loan Agent, Regions Bank, as 2021 Secured Notes Trustee, 2023 Secured Notes Trustee, 2024 Secured Notes Trustee, 2025 Secured Notes Trustee, 2026 Secured Notes Trustee, 2027 Secured Notes Trustee, Junior-Priority Collateral Agent, 2023 Junior-Priority Secured Notes Trustee and 2024 Junior-Priority Secured Notes Trustee, CHS/Community Health Systems, Inc., Community Health Systems, Inc., the subsidiary guarantors party thereto and each additional agent from time to time party thereto (incorporated by reference to Exhibit 4.04 to Community Health Systems, Inc.'s Current Report on Form 8-K filed June 25, 2018 (No.

Amended and Restated Junior-Priority Collateral Agreement, dated as of February 2, 2021, among CHS/Community Health Systems, Inc., Community Health Systems, Inc., the grantors named therein and Regions Bank, as Collateral Agent (incorporated by reference to Exhibit 4.2 to Community Health Systems, Inc.'s Current Report on Form 8-K filed February 2, 2021 (No.

Senior-Junior Lien Intercreditor Agreement, dated as of June 22, 2018, among CHS/Community Health Systems, Inc., Community Health Systems, Inc., the subsidiaries party thereto, Credit Suisse AG, Cayman Islands Branch, as Initial Senior-Priority Collateral Agent, Regions Bank, as Initial Junior-Priority Collateral Agent and each additional agent from time to time party thereto (incorporated by reference to Exhibit 4.05 to Community Health Systems, Inc.'s Current Report on Form 8-K filed June 25, 2018 (No.

Junior-Priority Lien Pari Passu Intercreditor Agreement, dated as of June 22, 2018, among Regions Bank, as Collateral Agent, Regions Bank, in its capacity as Trustee under the 2023 Notes Indenture, Regions Bank, in its capacity as Trustee under the 2024 Notes Indenture and each additional authorized representative from time to time party thereto (incorporated by reference to Exhibit 4.06 to Community Health Systems, Inc.'s Current Report on Form 8-K filed June 25, 2018 (No.

Second Amended and Restated Guarantee and Collateral Agreement, dated as of July 25, 2007, as amended and restated as of November 5, 2010, as further amended as of August 17, 2012, and as further amended and restated as of November 19, 2019, among CHS/Community Health Systems, Inc., Community Health Systems, Inc., the subsidiary guarantors party thereto and Credit Suisse AG, as Collateral Agent (incorporated by reference to Exhibit 4.5 to Community Health Systems, Inc.’s Current Report on Form 8-K filed November 19, 2019 (No.

ABL Credit Agreement, dated as of April 3, 2018, among CHS/Community Health Systems, Inc., as the Borrower, Community Health Systems, Inc., as the Parent, the subsidiaries of the Borrower party thereto, the lenders party thereto, and JPMorgan Chase Bank, N.A., as Administrative Agent and Collateral Agent (incorporated by reference to Exhibit 10.1 to Community Health Systems, Inc.'s Current Report on Form 8-K filed April 3, 2018 (No.

Amendment No.

1 to ABL Credit Agreement, dated as of May

Agent (incorporated by reference to Exhibit 10.4 to Community Health Systems, Inc.s Quarterly Report on Form 10-Q for the quarter ended June 30, 2018 filed July 27, 2018 (No.

1 to ABL Credit Agreement, dated as of May 3, 2018, among CHS/Community Health Systems, Inc., as the Borrower, Community Health Systems, Inc., as the Parent, the subsidiaries of the Borrower party thereto, the lenders party thereto, and JPMorgan Chase Bank, N.A., as Administrative Agent and Collateral Agent (incorporated by reference to Exhibit 10.4 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2018 filed July 27, 2018 (No.

Amendment No.

2 to ABL Credit Agreement, dated as of November

12, 2019, among CHS/Community Health Systems, Inc., as the Borrower, Community Health Systems, Inc., as the Parent, the subsidiaries of the Borrower party thereto, the lenders party thereto, and JPMorgan Chase Bank, N.A., as Administrative Agent and Collateral

Guarantee and Collateral Agreement to ABL Credit Agreement, dated as of April

3, 2018, among CHS/Community Health Systems, Inc., as the Borrower, Community Health Systems, Inc., as the Parent, the subsidiaries of the Borrower party thereto, and JPMorgan Chase Bank, N.A., as Collateral Agent (incorporated by reference to Exhibit 10.4

to Community Health Systems, Inc.s Quarterly Report on Form 10-Q for the quarter ended March 31, 2018 filed May 2, 2018 (No.

2 to ABL Credit Agreement, dated as of November 12, 2019, among CHS/Community Health Systems, Inc., as the Borrower, Community Health Systems, Inc., as the Parent, the subsidiaries of the Borrower party thereto, the lenders party thereto, and JPMorgan Chase Bank, N.A., as Administrative Agent and Collateral Agent (incorporated by reference to Exhibit 10.4 to Community Health Systems, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2019 filed February 20, 2020 (No.

Guarantee and Collateral Agreement to ABL Credit Agreement, dated as of April 3, 2018, among CHS/Community Health Systems, Inc., as the Borrower, Community Health Systems, Inc., as the Parent, the subsidiaries of the Borrower party thereto, and JPMorgan Chase Bank, N.A., as Collateral Agent (incorporated by reference to Exhibit 10.4 to Community Health Systems, Inc.'s Quarterly Report on Form 10-Q for the quarter ended March 31, 2018 filed May 2, 2018 (No.

Form of Indemnification Agreement between Community Health Systems, Inc.

and its directors and executive officers (incorporated by reference

to Exhibit 10.8 to Amendment No.

2 to Community Health Systems, Inc.s Registration Statement on Form S-1/A filed May 2, 2000

and its directors and executive officers (incorporated by reference to Exhibit 10.8 to Amendment No.

2 to Community Health Systems, Inc.’s Registration Statement on Form S-1/A filed May 2, 2000 (No.

CHS/Community Health Systems, Inc.

Amended and Restated Supplemental Executive Retirement Plan, as amended and restated as of January 1,

2009 (incorporated by reference to Exhibit 10.13 to Community Health Systems, Inc.s Annual Report on Form 10-K for the year ended December 31, 2008 filed February 27, 2009 (No.

Amended and Restated Supplemental Executive Retirement Plan, as amended and restated as of January 1, 2009 (incorporated by reference to Exhibit 10.13 to Community Health Systems, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2008 filed February 27, 2009 (No.

Amendment No.

1, dated as of September

13, 2011, to the CHS/Community Health Systems, Inc.

Amended and Restated Supplemental Executive Retirement Plan, as amended and restated as of January 1, 2009 (incorporated by reference to Exhibit

10.1 to Community Health Systems, Inc.s Quarterly Report on Form 10-Q for the quarter ended September 30, 2011 filed October

28, 2011 (No.

1, dated as of September 13, 2011, to the CHS/Community Health Systems, Inc.

Amended and Restated Supplemental Executive Retirement Plan, as amended and restated as of January 1, 2009 (incorporated by reference to Exhibit 10.1 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2011 filed October 28, 2011 (No.

Amendment No.

2, dated as of January

1, 2014, to the CHS/Community Health Systems, Inc.

Amended and Restated Supplemental Executive Retirement Plan, as amended and restated as of January

1, 2009 (incorporated by reference to Exhibit 10.1 to Community Health Systems, Inc.s Quarterly Report on Form 10-Q for the quarter ended March 31, 2014 filed May 7, 2014 (No.

2, dated as of January 1, 2014, to the CHS/Community Health Systems, Inc.

CHS/Community Health Systems, Inc.

2018 Supplemental Executive Retirement Plan, executed on May 15, 2018 and effective January

1, 2018 (incorporated by reference to Exhibit 10.5 to Community Health Systems, Inc.s Quarterly Report on Form 10-Q for the quarter ended June 30, 2018 filed July 27, 2018 (No.

Supplemental Executive Retirement Plan Trust, dated June

1, 2005, by and between CHS/Community Health Systems, Inc., as grantor, and Wachovia Bank, N.A., as Trustee (incorporated by reference to Exhibit

10.3 to Community Health Systems, Inc.s Current Report on Form 8-K filed June 1, 2005 (No.

Community Health Systems Supplemental Executive Benefits, dated December 31, 2008, as amended and restated as of April 1, 2015 and December 11, 2019

2018 Supplemental Executive Retirement Plan, executed on May 15, 2018 and effective January 1, 2018 (incorporated by reference to Exhibit 10.5 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2018 filed July 27, 2018 (No.

Supplemental Executive Retirement Plan Trust, dated June 1, 2005, by and between CHS/Community Health Systems, Inc., as grantor, and Wachovia Bank, N.A., as Trustee (incorporated by reference to Exhibit 10.3 to Community Health Systems, Inc.’s Current Report on Form 8-K filed June 1, 2005 (No.

Community Health Systems Supplemental Executive Benefits, dated December 31, 2008, as amended and restated as of April 1, 2015 and December 11, 2019 (incorporated by reference to Exhibit 10.12 to Community Health Systems, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2019 filed February 20, 2020 (No.

CHS/Community Health Systems, Inc.

Deferred Compensation Plan, amended and restated effective January

1, 2014 (incorporated by reference to Exhibit 10.25 to Community Health Systems, Inc.s Annual Report on Form 10-K for the year ended December 31, 2013 filed February 26, 2014 (No.

Community Health Systems Deferred Compensation Plan Trust, amended and restated effective February

26, 1999 (incorporated by reference to Exhibit 10.18 to Community Health Systems, Inc.s Annual Report on Form 10-K for the year ended December 31, 2002 filed March 27, 2003 (No.

CHS NQDCP, effective as of September

1, 2009 (incorporated by reference to Exhibit 4.2 to Community Health Systems, Inc.s Registration Statement on Form S-8 filed December

11, 2009 (No.

CHS NQDCP Adoption Agreement, executed as of August

11, 2009 (incorporated by reference to Exhibit 4.3 to Community Health Systems, Inc.s Registration Statement on Form S-8 filed December

11, 2009 (No.

Guarantee, dated December

9, 2009, made by Community Health Systems, Inc.

Deferred Compensation Plan, amended and restated effective January 1, 2014 (incorporated by reference to Exhibit 10.25 to Community Health Systems, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2013 filed February 26, 2014 (No.

Community Health Systems Deferred Compensation Plan Trust, amended and restated effective February 26, 1999 (incorporated by reference to Exhibit 10.18 to Community Health Systems, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2002 filed March 27, 2003 (No.

CHS NQDCP, effective as of September 1, 2009 (incorporated by reference to Exhibit 4.2 to Community Health Systems, Inc.’s Registration Statement on Form S-8 filed December 11, 2009 (No.

CHS NQDCP Adoption Agreement, executed as of August 11, 2009 (incorporated by reference to Exhibit 4.3 to Community Health Systems, Inc.’s Registration Statement on Form S-8 filed December 11, 2009 (No.

Guarantee, dated December 9, 2009, made by Community Health Systems, Inc.

in favor of CHS/Community Health Systems, Inc.

with respect to CHS/Community Health Systems, Inc.’s payment obligations under the CHS/Community Health Systems, Inc.

Deferred Compensation Plan and the

NQDCP (incorporated by reference to Exhibit 4.4 to Community Health Systems, Inc.s Registration Statement on Form S-8 filed December 11, 2009 (No.

Deferred Compensation Plan and the NQDCP (incorporated by reference to Exhibit 4.4 to Community Health Systems, Inc.’s Registration Statement on Form S-8 filed December 11, 2009 (No.

Community Health Systems, Inc.

2019 Employee Performance Incentive Plan (incorporated by reference to Exhibit 10.1 to Community Health Systems,

Inc.s Current Report on Form 8-K filed February 22, 2019 (No.

2019 Employee Performance Incentive Plan (incorporated by reference to Exhibit 10.1 to Community Health Systems, Inc.'s Current Report on Form 8-K filed February 22, 2019 (No.

Community Health Systems, Inc.

Directors Fees Deferral Plan, as amended and restated as of December

10, 2008 (incorporated by reference to Exhibit 10.15 to Community Health Systems, Inc.s Annual Report on Form 10-K for the year ended December 31, 2008 filed February 27, 2009 (No.

Directors’ Fees Deferral Plan, as amended and restated as of December 10, 2008 (incorporated by reference to Exhibit 10.15 to Community Health Systems, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2008 filed February 27, 2009 (No.

Community Health Systems, Inc.

2000 Stock Option and Award Plan, as amended and restated as of March

20, 2013 (incorporated by reference to Exhibit 10.1 to Community Health Systems, Inc.s Quarterly Report on Form 10-Q for the quarter ended June 30, 2013 filed July 31, 2013 (No.

2000 Stock Option and Award Plan, as amended and restated as of March 20, 2013 (incorporated by reference to Exhibit 10.1 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2013 filed July 31, 2013 (No.

Form of Nonqualified Stock Option Agreement (Employee) for Community Health Systems, Inc.

2000 Stock Option and Award Plan (incorporated by

reference to Exhibit 10.15 to Community Health Systems, Inc.s Annual Report on Form 10-K for the year ended December 31, 2009 filed February 26, 2010 (No.

2000 Stock Option and Award Plan (incorporated by reference to Exhibit 10.15 to Community Health Systems, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2009 filed February 26, 2010 (No.

Community Health Systems, Inc.

2009 Stock Option and Award Plan, as amended and restated as of March

14, 2018 (incorporated by reference to Exhibit 10.1 to Community Health Systems, Inc.s Current Report on Form 8-K filed May

15, 2018 (No.

2009 Stock Option and Award Plan, as amended and restated as of March 20, 2020 (incorporated by reference to Exhibit 10.1 to Community Health Systems, Inc.’s Current Report on Form 8-K filed May 13, 2020 (No.

Form of Nonqualified Stock Option Agreement (Employee) for Community Health Systems, Inc.

2009 Stock Option and Award Plan (incorporated by

reference to Exhibit 10.39 to Community Health Systems, Inc.s Annual Report on Form 10-K for the year ended December 31, 2013 filed February 26, 2014 (No.

2009 Stock Option and Award Plan (incorporated by reference to Exhibit 10.39 to Community Health Systems, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2013 filed February 26, 2014 (No.

Form of Restricted Stock Award Agreement for Community Health Systems, Inc.

2009 Stock Option and Award Plan (incorporated by reference to Exhibit

10.3 to Community Health Systems, Inc.s Quarterly Report on Form 10-Q for the quarter ended June 30, 2013 filed July 31, 2013 (No.

Form of Performance Based Restricted Stock Award Agreement (Most Highly Compensated Executive Officers) for Community Health Systems, Inc.

Stock Option and Award Plan (for awards granted from March 1, 2016 through February 28, 2017) (incorporated by reference to Exhibit 10.1 to Community Health Systems, Inc.s Quarterly Report on

Form 10-Q for the quarter ended March 31, 2016 filed May 3, 2016 (No.

2009 Stock Option and Award Plan (incorporated by reference to Exhibit 10.3 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2013 filed July 31, 2013 (No.

Form of Performance Based Restricted Stock Award Agreement (Senior Officers) for Community Health Systems, Inc.

2009 Stock Option and Award Plan

(for awards granted from March 1, 2017 through February 28, 2018) (incorporated by reference to Exhibit 10.2 to Community Health Systems, Inc.s Quarterly Report on Form 10-Q

for the quarter ended March 31, 2017 filed May 2, 2017 (No.

2009 Stock Option and Award Plan (for awards granted on or after March 1, 2018 through February 29.

2020) (incorporated by reference to Exhibit 10.46 to Community Health Systems, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2017 filed February 28, 2018 (No.

Form of Performance Based Restricted Stock Award Agreement (Senior Officers) for Community Health Systems, Inc.

2009 Stock Option and Award

Plan (for awards granted beginning March 1, 2018) (incorporated by reference to Exhibit 10.46 to Community Health Systems, Inc.s Annual Report on Form 10-K for the year ended December 31, 2017

filed February 28, 2018 (No.

2009 Stock Option and Award Plan (for awards granted on or after March 1, 2020) (incorporated by reference to Exhibit 10.1 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2020 filed April 29, 2020 (No.

Form of Director Restricted Stock Unit Award Agreement for Community Health Systems, Inc.

2009 Stock Option and Award Plan (incorporated by reference

to Exhibit 10.1 to Community Health Systems, Inc.s Quarterly Report on Form 10-Q for the quarter ended September 30, 2019 filed October 30, 2019 (No.

Form of Amended and Restated Change in Control Severance Agreement effective December

31, 2008 (incorporated by reference to Exhibit 10.22 to Community Health Systems, Inc.s Annual Report on Form 10-K for the year ended December 31, 2008 filed February

27, 2009 (No.

Form of Change in Control Severance Agreement (for executive officers appointed since January

1, 2009) (incorporated by reference to Exhibit 10.3 to Community Health Systems, Inc.s Quarterly Report on Form 10-Q for the quarter ended March 31, 2014 filed May 7, 2014 (No.

Participation Agreement entered into as of January

1, 2005, by and between Community Health Systems Professional Services Corporation and HealthTrust Purchasing Group, L.P.

2009 Stock Option and Award Plan (for awards granted prior to September 11, 2019) (incorporated by reference to Exhibit 10.5 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2013 filed July 31, 2013 (No.

Form of Director Restricted Stock Unit Award Agreement for Community Health Systems, Inc.

2009 Stock Option and Award Plan (for awards granted on or after September 11, 2019)(incorporated by reference to Exhibit 10.1 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2019 filed October 30, 2019 (No.

Form of Amended and Restated Change in Control Severance Agreement effective December 31, 2008 (incorporated by reference to Exhibit 10.22 to Community Health Systems, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2008 filed February 27, 2009 (No.

Form of Change in Control Severance Agreement (for executive officers appointed since January 1, 2009) (incorporated by reference to Exhibit 10.3 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2014 filed May 7, 2014 (No.

Participation Agreement entered into as of January 1, 2005, by and between Community Health Systems Professional Services Corporation and HealthTrust Purchasing Group, L.P.

(incorporated by reference to Exhibit 10.1 to Community Health Systems, Inc.’s Current Report on Form 8-K filed January 7, 2005 (No.

Amendment effective as of January

1, 2015, by and between CHSPSC, LLC and HealthTrust Purchasing Group, L.P., to Participation Agreement entered into as of January

1, 2005, by and between Community Health Systems Professional Services Corporation and HealthTrust Purchasing Group, L.P.

Amendment effective as of January 1, 2015, by and between CHSPSC, LLC and HealthTrust Purchasing Group, L.P., to Participation Agreement entered into as of January 1, 2005, by and between Community Health Systems Professional Services Corporation and HealthTrust Purchasing Group, L.P.

(incorporated by reference to Exhibit 10.36 to Community Health Systems, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2014 filed February 25, 2015 (No.

Consultancy Agreement, dated December

31, 2019, by and between CHSPSC, LLC and Thomas J.

Aaron (incorporated by reference to Exhibit 10.1 to Community Health Systems, Inc.s Current Report on Form 8-K filed January 2, 2020 (No.

Executive Deferred Compensation Award between Kevin Hammons and CHSPSC, LLC, dated December 12, 2017

Executive Deferred Compensation Award between Kevin Hammons and CHSPSC, LLC, dated December 12, 2017 (incorporated by reference to Exhibit 10.34 to Community Health Systems, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2019 filed February 20, 2020 (No.

Executive Deferred Compensation Award between Dr.

Lynn Simon and CHSPSC, LLC, dated December

12, 2017 (incorporated by reference to Exhibit 10.54 to Community Health Systems, Inc.s Annual Report on Form 10-K for the year ended December 31, 2017 filed February 28, 2018 (No.

Lynn Simon and CHSPSC, LLC, dated December 12, 2017 (incorporated by reference to Exhibit 10.54 to Community Health Systems, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2017 filed February 28, 2018 (No.

List of Subsidiaries

List of Subsidiary Guarantors and Issuers of Guaranteed Securities

Consent of Deloitte & Touche LLP

5 unchanged sentences

Section 1350, adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Corporate Integrity Agreement, Amended, dated September

21, 2018, between Community Health Systems, Inc.

and the Office of Inspector General of the United States Department of Health and Human Services (incorporated by reference to Exhibit 99.1 to Community Health Systems, Inc.s Quarterly Report on Form

10-Q for the quarter ended September 30, 2018 filed October 30, 2018 (No.

Order Approving Derivative Settlement and Order of Dismissal with Prejudice, dated January

17, 2017 and Stipulation of Settlement, dated November

18, 2016 (incorporated by reference to Exhibit 99.2 to Community Health Systems, Inc.s Annual Report on Form 10-K for the year ended December 31, 2016 filed February 21, 2017 (No.

XBRL Instance Document

XBRL Taxonomy Extension Schema

XBRL Taxonomy Extension Calculation Linkbase

XBRL Taxonomy Extension Definition Linkbase

XBRL Taxonomy Extension Label Linkbase

XBRL Taxonomy Extension Presentation Linkbase

Corporate Integrity Agreement, Amended, dated September 21, 2018, between Community Health Systems, Inc.

and the Office of Inspector General of the United States Department of Health and Human Services (incorporated by reference to Exhibit 99.1 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2018 filed October 30, 2018 (No.

The following financial information from our annual report on Form 10-K for the year ended December 31, 2020, filed with the SEC on February 18, 2021, formatted in Inline Extensible Business Reporting Language:

(i) the consolidated statements of income (loss) for the years ended December 31, 2020, 2019 and 2018, (ii) the consolidated statements of comprehensive income (loss) for the years ended December 31, 2020, 2019 and 2018, (iii) the consolidated balance sheets at December 31, 2020 and December 31, 2019, (iv) the consolidated statements of stockholders’ (deficit) equity for the years ended December 31, 2020, 2019 and 2018, (v) the consolidated statements of cash flows for the years ended December 31, 2020, 2019 and 2018, and (vi) the notes to the consolidated financial statements.

The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

Filed herewith.

1 unchanged sentence

Indicates a management contract or compensatory plan or arrangement.

Pursuant to the requirements of section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be

signed on its behalf by the undersigned, thereunto duly authorized.

C OMMUNITY H EALTH S YSTEMS , I NC .

Chairman of the Board

and Chief Executive Officer

Form 10-K Summary

Pursuant to the requirements of section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Community Health Systems, Inc.

Chief Executive Officer

February 18, 2021

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below

by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

Chairman of the Board and

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

Chief Executive Officer

February 18, 2021

Executive Vice President and

Chief Financial Officer

President and

February 18, 2021

Chief Financial Officer

Senior Vice President and

Chief Accounting Officer

February 18, 2021

President, Chief Operating Officer

Chief Accounting Officer

Executive Chairman of the

February 18, 2021

Board of Directors

February 18, 2021

/s/ Michael Dinkins

Michael Dinkins

February 18, 2021

Michael Dinkins

February 18, 2021

3 unchanged sentences

/s/ William Norris Jennings, M.D.

William Norris Jennings, M.D.

February 18, 2021

Ranga Krishnan, MBBS

William Norris Jennings, M.D.

Ranga Krishnan, MBBS

February 18, 2021

Ranga Krishnan, MBBS

February 18, 2021

James Williams, Ph.D.

February 18, 2021

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Stockholders and the Board of Directors of

Health Systems, Inc.

Franklin, Tennessee

Opinion on the

Financial Statement Schedule

We have audited the consolidated financial statements of Community Health Systems, Inc., and subsidiaries (the

Company) as of December 31, 2019 and 2018, and for each of the three years in the period ended December 31, 2019, and the Companys internal control over financial reporting as of December 31, 2019, and have issued

our reports thereon dated February 20, 2020;

such reports are included elsewhere in this Form 10-K.

Our audits also included the consolidated financial statement schedule of the Company listed in the

Index at Item 15.

This financial statement schedule is the responsibility of the Companys management.

Our responsibility is to express an opinion on the Companys financial statement schedule based on our audits.

In our opinion, such

financial statement schedule, when considered in relation to the financial statements taken as a whole, presents fairly, in all material respects, the information set forth therein.

/s/ Deloitte & Touche LLP

Nashville, Tennessee

February 20, 2020

Community Health Systems, Inc.

and Subsidiaries

Schedule II Valuation and Qualifying Accounts

(In millions)

Year ended December 31, 2019

allowance for doubtful accounts (1)

Year ended December 31, 2018

allowance for doubtful accounts (1)

Year ended December 31, 2017

allowance for doubtful accounts

As discussed at Note 1 of the Notes of the Consolidated Financial Statements, on January 1, 2018, the

Company adopted the new revenue recognition standard codified in ASC 606.

Upon adoption of ASC 606, the allowance for doubtful accounts of approximately $3.9 billion was reclassified as a component of the net patient accounts receivable.

James Williams, Ph.D.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 9A. Controls and Procedures